Claims: in ivermectin trial results

1 claims
Narrow claims Pick any combination. Press Enter to apply typed text.
Clear filters
Speaker
Target
Topic
Certainty
Claim text
Date range
17 Dec 2025
A trial report concludes that ivermectin for COVID-19 is unlikely to provide clinically meaningful improvement in recovery or hospital admissions.

So this is their take home message from the paper. It says ivermectin for COVID-19 is unlikely to provide a clinically meaningful improvement in recovery, hospital admissions or longer term outcomes. Further trials of ivermectin for SARS-CoV-2 infection in vaccinated community populations appear unwarranted.